Clinical Performance Evaluation of MagIA IVD-MD Multiplex Testing (HIV/HBV/HCV/Syphilis)
Recruiting
Observational Study
Multiplex Testing of HIV, HBV, HCV and Syphilis
HIV
HBV
HCV
Syphilis
Point of Care Testing
Healthy Volunteers Welcome
You do not need to have the condition being studied to take part.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 18 and older
- Sex
- Any
- Study type
- Observational
- Participants needed
- 2,950 (estimated)
- Sponsor
- MagIA Diagnostics · Industry
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
Performance study to evaluate the clinical performance of the In-Vitro Diagnostics Medical Device MagIA H3S (a Multiplex Point-of-Care test for the combined detection of Human Immunodeficiency Virus (HIV), Hepatitis B and C and Syphilis) from serum, plasma samples collected prospectively or retrospectively in Ivory Coast and Kenya.
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Provide informed consent for participation in this study.
* Patient sample must meet at least one of the criteria below:
1\. Positive samples (serum or plasma) from individuals who meet at least one of the following conditions:
* HIV-1 Ab positive
* HIV-2 Ab positive
* HCV-…
Contacts
No contact information available.